International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Pain-Away II Headache Capsules

Author(s): Allen Loyd V Jr

Issue: May/Jun 2016 - Volume 20, Number 3
View All Articles in Issue

Page(s): 233

Download in electronic PDF format for $75

Abstract: A formulation for preparing Pain-Away II Headache Capsules. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, ketoprofen, nonsteroidal anti-inflammatory drug, NSAID, headache, formulation, riboflavin, caffeine, pain, analgesic, analgesia, Ketoprofen Plus headache capsules

Related Categories: FORMULATIONS, PAIN MANAGEMENT, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Pain-Away II Headache Capsules Allen Loyd V Jr	May/Jun 2016 Pg. 233
Case Report: Ketoprofen/Riboflavin/Caffeine Capsules and Progesterone Therapy for Recurrent Migraine Pain Fields Shannon W	May/Jun 2007 Pg. 200
A Concise Discussion of Headache Types, Part 1 Williams LaVonn A	Mar/Apr 2012 Pg. 125-132
A Concise Discussion of Headache Types, Part 3: Migraine Williams LaVonn A, Allen Loyd V Jr	Jul/Aug 2012 Pg. 270-274
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Managing Pain with Transdermal Ketoprofen Williams KaCee D	May/Jun 2010 Pg. 204-206
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Jul/Aug 2014 Pg. 278-286
Compounded Pain Formulations: What is the Evidence? Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso	Mar/Apr 2024 Pg. 100-109
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Topical Medications for Orofacial Neuropathic Pain Bramwell Bethany L	May/Jun 2010 Pg. 200-203
Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 514
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Mar/Apr 2024 Pg. 111-116
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Allen Loyd V Jr	Mar/Apr 2011 Pg. 157
Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Allen Loyd V Jr	Mar/Apr 2024 Pg. 131
Ketoprofen 10% in Pluronic Lecithin Organogel Allen Loyd V Jr	Jan/Feb 2019 Pg. 52
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 53
Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Allen Loyd V Jr	Nov/Dec 2010 Pg. 513
Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Allen Loyd V Jr	Nov/Dec 2010 Pg. 520
Return to Top